Early HIV diagnosis and treatment important for better long-term health outcomes
On Oct. 24, 2022, the National Institutes of Health announced that starting antiretroviral treatment (ART) early in the…
On Oct. 24, 2022, the National Institutes of Health announced that starting antiretroviral treatment (ART) early in the…
On Oct. 20, 2022, the National Institutes of Health announced that a three-dose course of the hepatitis B…
On Supt. 22, 2022, with a five-year, $126 million grant from the National Institutes of Health (NIH), a…
On Sept. 15, 2022, the National Institutes of Health announced that a research team funded by the NIH…
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
On Jul. 5, 2022, the National Institutes of Health and National Cancer Institute announced COVID-19 was the third…
On Jun. 28, 2022, the National Institutes of Health (NIH) announced that a Phase 1 clinical trial of…
On Jun. 2, 2022, the National Institutes of Health reported that the Age-Related Eye Disease Studies (AREDS and…
On Jun. 1, 2022, the U.S. National Institutes of Health announced that an NIH funded study had found…
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
On Mar. 17, 2022, the National Institutes of Health announced that nearly 100,000 highly diverse whole genome sequences…
On Mar. 14, 2022, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) has launched a…
On Mar. 10, 2022, Schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
On Feb. 8, 2022, Merck and Ridgeback Biotherapeutics announced that a total of 3.1 million courses of molnupiravir,…
On Feb. 4, 2022, the NIH announced a study that showed pregnant women with COVID-19 appeared to be…
On Feb. 4, 2022, the NIH reported that Staphylococcus epidermidis produces enzymes, known as sphingomyelinase, that help the…
On Feb. 2, 2022, President Biden announced a reignition of the Cancer Moonshot, that highlighted new goals: to…
On Jan. 26, 2022, the NIH announced that adults who had previously received a full regimen of any…
On Jan. 20, 2022, scientists from the National Institute of Allergy and Infectious Diseases (NIAID) announced that they…
On Jan. 20, 2022, the National Institutes of Health announced it was awarding $170 million over five years,…
On Jan 5, 2022, NRx Pharmaceuticals announced that it had submitted an application for Emergency Use Authorization (EUA)…
On Dec. 16, 2021, NIH scientists announced that to counter future coronavirus outbreaks, the global scientific and medical…
On Oct. 18, 2021, the National Institutes of Health launched a program to study a rare type of…
On Oct. 14, 2021, The NIH Rapid Acceleration of Diagnostics (RADx) initiative announced that it has issued contract…
On Oct. 7, 2021, BD (Becton, Dickinson) announced it had strengthened the U.S. government’s access to safety injection…
On Oct. 6, 2021, the The NIH Brain Research through Advancing Innovative Neurotechnologiesï¾® (BRAIN?) Initiative Cell Census Network…
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
On Sept. 14, 2021, the NIH announced that an international project called the COVID Human Genetic Effort has…
On Sept. 9, 2021, the NIH announced that it was providing approximately $185 million over five years to…